Postpartum depression

Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress

Retrieved on: 
Wednesday, February 14, 2024

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2023.
  • Revenue: Collaboration revenue from sales of ZURZUVAE was $0.8 million in the fourth quarter of 2023, the first quarter of sales.
  • Net Loss: Net loss was $32.7 million for the fourth quarter of 2023 compared to $147.1 million for the same period in 2022.
  • ET to review its fourth quarter and full year 2023 financial results and discuss recent corporate updates.

Global Anxiety Disorders And Depression Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Distribution Channel; and By Region - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 8, 2024

The "Global Anxiety Disorders And Depression Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Distribution Channel; and By Region" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Anxiety Disorders And Depression Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Distribution Channel; and By Region" report has been added to ResearchAndMarkets.com's offering.
  • The global anxiety disorders and depression treatment market size was estimated to be USD 21.56 billion in 2023 and is expected to reach at USD 41.83 billion by 2034 with a CAGR of 6.21% during the forecast period 2024-2034.
  • Rising research & development activities for the development of innovative drugs for the treatment of anxiety & depression disorders is predicted to boost the market growth during the forecast period.
  • This application pertains to the use of cariprazine as an add-on treatment for individuals with major depressive disorder (MDD) who are already undergoing antidepressant therapy.

Sage Therapeutics to Provide Business Updates at 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Monday, January 8, 2024

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced that Chief Executive Officer Barry Greene will discuss the Company’s key business drivers for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California.

Key Points: 
  • Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced that Chief Executive Officer Barry Greene will discuss the Company’s key business drivers for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California.
  • Sage and Biogen field sales teams are engaging in promotional dialogues with health care professionals (HCPs) who actively identify and treat women with PPD.
  • Sage is advancing a portfolio of early-stage and clinical programs featuring internally discovered novel chemical entities targeting the GABAA and NMDA receptor systems.
  • A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

New Spiritual Memoir Invites Readers On A Deeply Personal Journey of Self Rediscovery And Freedom From Debilitating Postpartum Depression

Retrieved on: 
Wednesday, December 6, 2023

Charleston, SC, Dec. 06, 2023 (GLOBE NEWSWIRE) -- According to the NHS, over 1 in 10 women who give birth are affected with postpartum depression.

Key Points: 
  • Charleston, SC, Dec. 06, 2023 (GLOBE NEWSWIRE) -- According to the NHS, over 1 in 10 women who give birth are affected with postpartum depression.
  • Shirley Motorca understands firsthand the exhausting, paralyzing role that postpartum depression can play.
  • She invites readers on an intimate journey in her newest book, Don't Ever Let Go: Finding Freedom in Christ Amidst the Trials of Postpartum Depression, that takes readers from the lowest point of her postpartum depression to the freedom found in her identity in Christ.
  • Don't Ever Let Go: Finding Freedom in Christ Amidst the Trials of Postpartum Depression is available for purchase online at Amazon.com and Barnes and Noble.com .

Point32Health Announces Three Finalists in Second Annual Innovation Challenge

Retrieved on: 
Wednesday, October 18, 2023

"The three finalists for this year's Innovation Challenge are pushing boundaries within the health care industry and developing solutions that are already improving health outcomes," said Glenn Pomerantz, MD, JD, Point32Health chief medical officer.

Key Points: 
  • "The three finalists for this year's Innovation Challenge are pushing boundaries within the health care industry and developing solutions that are already improving health outcomes," said Glenn Pomerantz, MD, JD, Point32Health chief medical officer.
  • The Innovation Challenge is an opportunity for one or more of these companies to work with Point32Health on a pilot or program, funded by the insurer.
  • Representatives from each company will attend the Innovation Challenge and present their industry innovations to the Point32Health leadership team at the company's headquarters in Canton, Massachusetts on November 15, 2023.
  • Any questions about the Innovation Challenge can be sent to: [email protected] .

Bragar Eagel & Squire, P.C. Is Investigating DigitalOcean, and Sage and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, September 2, 2023

NEW YORK, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against DigitalOcean Holdings, Inc. (NYSE: DOCN), and Sage Therapeutics, Inc. (NASDAQ: SAGE).

Key Points: 
  • NEW YORK, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against DigitalOcean Holdings, Inc. (NYSE: DOCN), and Sage Therapeutics, Inc. (NASDAQ: SAGE).
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Additional information about each case can be found at the link provided.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

When being a new mum feels overwhelming, here's some expert advice on what you need to know

Retrieved on: 
Tuesday, August 29, 2023

Yes, they may love their baby very much but the broader impact of having a baby and becoming a mother can feel far more complex.

Key Points: 
  • Yes, they may love their baby very much but the broader impact of having a baby and becoming a mother can feel far more complex.
  • Research shows that when we look at happiness over our lifetime, the year after having a baby can be one of our lowest points.
  • It’s not about our relationship with our baby but rather the other parts of our lives that have changed so much.
  • We are all tempted to just share the best bits, thinking we need to hide our feelings because we think everyone else is so happy.
  • You might feel trapped, wanting to escape yet at the same time feeling you can’t leave your baby.
  • Sometimes these feelings are linked to physical events during the birth, but often they’re more about how you felt or were treated.

Getting support

    • Many doulas (a person who can support you through pregnancy, labour and birth) also offer help to explore how you are feeling about your birth and caring for your baby.
    • Focus on looking after yourself, too: Your diet, activity levels and time outdoors can all affect how you feel.
    • Try baby massage: It can help you to slow down and connect with your baby.
    • Often mothers experiencing mental health difficulties are highly attuned to their baby’s needs because they are so worried about not getting it right.

Bragar Eagel & Squire, P.C. Is Investigating Blink, Lovesac, and Sage and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, August 28, 2023

NEW YORK, Aug. 27, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Blink Charging Co. (NASDAQ: BLNK), Lovesac Company (NASDAQ: LOVE), and Sage Therapeutics, Inc. (NASDAQ: SAGE).

Key Points: 
  • NEW YORK, Aug. 27, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Blink Charging Co. (NASDAQ: BLNK), Lovesac Company (NASDAQ: LOVE), and Sage Therapeutics, Inc. (NASDAQ: SAGE).
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Additional information about each case can be found at the link provided.
  • On this news, Sage's stock price fell $19.35 per share, or 53.6%, to close at $16.75 per share on August 7, 2023.

SAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating Sage Therapeutics, Inc. on Behalf of Sage Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, August 22, 2023

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Sage Therapeutics, Inc. (“Sage” or the “Company”) (NASDAQ: SAGE) on behalf of Sage stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Sage Therapeutics, Inc. (“Sage” or the “Company”) (NASDAQ: SAGE) on behalf of Sage stockholders.
  • Our investigation concerns whether Sage has violated the federal securities laws and/or engaged in other unlawful business practices.
  • Click here to participate in the action.
  • On this news, Sage's stock price fell $19.35 per share, or 53.6%, to close at $16.75 per share on August 7, 2023.

What to expect when you're expecting: How will your sex life change during pregnancy and postpartum?

Retrieved on: 
Monday, July 24, 2023

Welcoming a new baby is often a joyous experience for couples.

Key Points: 
  • Welcoming a new baby is often a joyous experience for couples.
  • We then use this research to develop resources to help couples navigate these changes together.

What to expect

    • Up to 88 per cent of people who give birth and 45 per cent of their partners experience problems with their sex life during this time.
    • With shifting roles and responsibilities, the perinatal period (pregnancy and up to one year postpartum) can be hectic.
    • It’s understandable that sex may be on the back burner for a little while.

The information gap

    • This is despite most individuals wanting to receive sex-related information!
    • On top of this information gap, the content of information that couples receive doesn’t match what they want to receive.
    • In our study, we found that expectant and new parents most often received information about things like safety of sexual activity in pregnancy, contraception, when to resume sex in the postpartum and information only relevant to the partner who gave birth.

Translating knowledge into practice

    • Health-care professionals feel they have a lack of knowledge and training to talk about sexual health with expectant and new parents, and worry that doing so would make them and/or their patients feel uncomfortable.
    • However, our research showed that most couples would welcome these conversations.
    • Researchers at Dalhousie University recently produced a series of short informational videos that summarize recent research on sex after having a baby.